Nature 2006,443(7112):709–712.PubMedCrossRef 14. Taniguchi N, Taniura H, Niinobe M, Takayama C, Tominaga-Yoshino selleck screening library K, Ogura A, Yoshikawa K: The Ipatasertib order postmitotic growth suppressor necdin interacts with a calcium-binding protein (NEFA) in neuronal cytoplasm. J Biol Chem 2000,275(41):31674–31681.PubMedCrossRef 15. Islam A, Adamik B, Hawari FI, Ma G, Rouhani FN, Zhang J, Levine SJ: Extracellular TNFR1 release requires the calcium-dependent formation of a nucleobindin 2-ARTS-1 complex. J Biol Chem 2006,281(10):6860–6873.PubMedCrossRef 16. García-Galiano
D, Navarro VM, Gaytan F, Tena-Sempere M: Expanding roles of NUCB2/nesfatin-1 in neuroendocrine regulation. J Mol Endocrinol 2010,45(5):281–290.PubMedCrossRef 17. Kalnina Z, Silina K, Bruvere R, Gabruseva N, Stengrevics A, Barnikol-Watanabe S, Leja M, Line A: Molecular characterisation and expression analysis of SEREX-defined antigen NUCB2 in gastric epithelium, gastritis and gastric cancer.
Eur J Histochem 2009,53(1):7–18.PubMed 18. Suzuki S, Takagi K, Miki Y, Onodera Y, Akahira J, Ebata A, Ishida T, Watanabe M, Sasano H, Suzuki T: Nucleobindin 2 in human breast carcinoma as a potent prognostic factor. Cancer Sci 2012,103(1):136–143.PubMedCrossRef 19. Xiao M, Jia S, Wang H, Wang J, Huang Y, Li Z: Overexpression of LAPTM4B: an independent prognostic marker in breast cancer. J Cancer Res Clin Oncol 2013,139(4):661–667.PubMedCrossRef BB-94 20. Bracarda S, De Cobelli O, Greco C, Prayer-Galetti T, Valdagni R, Gatta G, De Braud F, Bartsch G: Cancer of the prostate. Crit Rev Oncol Hematol 2005,56(3):379–396.PubMedCrossRef 21. Zhou Y, Su Z, Huang Y, Sun T, Chen S, Wu T, Chen G, Xie X, Li B, Du Z: The Zfx gene is expressed in human gliomas and is important in the proliferation and apoptosis of the Cyclic nucleotide phosphodiesterase human malignant glioma cell line U251. J Exp Clin Cancer Res 2011, 30:114.PubMedCrossRef
22. Li Z, Tanaka H, Galiano F, Glass J: Anticancer activity of the iron facilitator LS081. J Exp Clin Cancer Res 2011, 30:34.PubMedCrossRef 23. Carroll PR: Early stage prostate cancer-do we have a problem with over-detection, overtreatment or both? J Urol 2005,173(4):1061–1062.PubMedCrossRef 24. Yang L, You S, Kumar V, Zhang C, Cao Y: In vitro the behaviors of metastasis with suppression of VEGF in human bone metastatic LNCaP-derivative C4–2B prostate cancer cell line. J Exp Clin Cancer Res 2012, 31:40.PubMedCrossRef 25. Xiang YZ, Xiong H, Cui ZL, Jiang SB, Xia QH, Zhao Y, Li GB, Jin XB: The association between metabolic syndrome and the risk of prostate cancer, high-grade prostate cancer, advanced prostate cancer, prostate cancer-specific mortality and biochemical recurrence. J Exp Clin Cancer Res 2013, 32:9.PubMedCrossRef 26.